Corrigendum to “Future directions for the discovery of natural product-derived immunomodulating drugs: An IUPHAR positional review” [Pharmacol. Res. 177 (2022) 106076]

• Cherry L. Wainwright,
• Mauro M. Teixeira,
• David L. Adelson,
• Eric J. Buenz,
• Bruno David,
• Keith B. Glaser,
• Yuka Harata-Lee,
• Melanie-Jayne R. Howes,
• Angelo A. Izzo,
• Pasquale Maffia,
• Alejandro M.S. Mayer,
• Claire Mazars,
• David J. Newman,
• Eimear Nic Lughadha,
• Adriano M.C. Pimenta,
• John A.A. Parra,
• Zhipeng Qu,
• Hanyuan Shen,
• Michael Spedding,
• Jean-Luc Wolfender

Affiliations

Cherry L. Wainwright

Centre for Natural Products in Health, Robert Gordon University, Aberdeen, UK; Corresponding author.

Mauro M. Teixeira

Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Brazil

David L. Adelson

Molecular & Biomedical Science, University of Adelaide, Australia

Eric J. Buenz

Nelson Marlborough Institute of Technology, New Zealand

Bruno David

Green Mission Pierre Fabre, Pierre Fabre Laboratories, Toulouse, France

Keith B. Glaser

AbbVie Inc., Integrated Discovery Operations, North Chicago, USA

Yuka Harata-Lee

Molecular & Biomedical Science, University of Adelaide, Australia

Melanie-Jayne R. Howes

Royal Botanic Gardens Kew, Richmond, Surrey, UK; Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King’s College London, UK

Angelo A. Izzo

Department of Pharmacy, School of Medicine, University of Naples Federico II, Italy

Pasquale Maffia

Department of Pharmacy, School of Medicine, University of Naples Federico II, Italy; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

Alejandro M.S. Mayer

Department of Pharmacology, College of Graduate Studies, Midwestern University, IL, USA

Claire Mazars

Green Mission Pierre Fabre, Pierre Fabre Laboratories, Toulouse, France

David J. Newman

NIH Special Volunteer, Wayne, PA, USA

Eimear Nic Lughadha

Royal Botanic Gardens Kew, Richmond, Surrey, UK

Adriano M.C. Pimenta

Laboratory of Animal Venoms and Toxins, Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

John A.A. Parra

Laboratory of Animal Venoms and Toxins, Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Zhipeng Qu

Molecular & Biomedical Science, University of Adelaide, Australia

Hanyuan Shen

Molecular & Biomedical Science, University of Adelaide, Australia

Michael Spedding

Spedding Research Solutions, Paris, France

Jean-Luc Wolfender

School of Pharmaceutical Sciences, University of Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland